American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Published on by Louise Davies

Louise Davies – White River Junction, VT

Practice Contact Information

Dartmouth College
215

White River Junction
VT
05009
United States

Phone: 802-296-5178
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon

Biography/Statement

I am a surgeon in the U.S. Department of Veterans Affairs health care system taking care of patients with thyroid and parathyroid disease, and head and neck cancer. I am also researcher, working to improve our understanding of the epidemiology of these diseases and how to optimize care for patients by understanding their experiences and maximizing quality of care to meet their needs.

Clinical Trials

Bibliography

Published on by John Ridge

John Ridge – PHILADELPHIA, PA

Practice Contact Information

Fox Chase Cancer Center
c303, Surgical Oncology

PHILADELPHIA
PA
19111
United States

Phone: 2157283517
Email: [email protected]
Web Site: https://www.foxchase.org/john-ridge

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon

Biography/Statement

I came to the department of surgical oncology at Fox Chase Cancer Center in 1991, moving from San Francisco to join one of the country’s first multispecialty head and neck cancer teams. Since then, I have dedicated my career to curing as many patients with head and neck cancer as possible, while providing all of them with the best quality of life.

I recognized years ago that many patients with head and neck cancer could be cured and enjoy a high quality of life if they were treated with radiation and sometimes with chemotherapy, instead of surgery. As a result, I have worked closely with other cancer specialists to care for many patients without radical surgery. The Fox Chase team is well-known and highly regarded because we work together to offer each patient the treatments that will help them best.

Head and neck cancer is uncommon, and modern treatment of head and neck cancer can be complex. Our experienced and talented team employs skills developed through years of working collaboratively to cure patients with these rare tumors. Together, we draw common threads to craft a plan for each patient.

Clinical Trials

Bibliography

This keeps changing.

Please look me up on pubmed.gov as “Ridge JA”

Thanks!

Published on by Daniel Pinheiro, MD PhD FACS

A DANIEL PINHEIRO – SPRINGFIELD, MO

Practice Contact Information

Mercy Clinic
1229 E. Seminole Street, Suite 520

SPRINGFIELD
MO
65804
United States

Phone: 417-820-5750
Email:
Web Site: https://www.mercy.net/doctor/a-daniel-pinheiro-md/

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon

Biography/Statement

I am proud to be part of an organization whose mission statement is to “… bring to life the healing ministry of Jesus through our compassionate care and exceptional service.” Compassionate care and exceptional service are the hallmark of our comprehensive, holistic and multidisciplinary care of those touched by tumors of the thyroid , parathyroid and the head and neck.

Clinical Trials

The following trials are currently available through CRO (Cancer Research of the Ozarks):

EA3132

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing

 

NRG-HN001

ClinicalTrials.gov NCT02135042

RANDOMIZED PHASE II AND PHASE III STUDIES OF INDIVIDUALIZED TREATMENT FOR NASOPHARYNGEAL CARCINOMA BASED ON BIOMARKER EPSTEIN BARR VIRUS (EBV) DEOXYRIBONUCLEIC ACID (DNA)

 

RTOG 0920

A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER

 

ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY

A091305

A PHASE 2 STUDY OF EFATUTAZONE, AN ORAL PPAR AGONIST, IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED ANAPLASTIC THYROID CANCER

WF 97115

A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer

ECOG-ACRIN EA 6134 – Randomizes between Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at progression or Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at progression.  BRAF V600 mutation is required, and patients must have Stage IV or unresectable Stage III, measurable disease.

SWOG S1320 – Randomizes between intermittent versus continuous dosing of Dabrafenib + Trametinib for BRAF V600E/K mutant, Stage IV or unresectable Stage III, melanoma. Again, patients must have measurable disease.

SWOG S1616 – Randomizes between Nivolumab + Ipilimumab or Ipilimumab alone in Stage IV or unresectable Stage III melanoma patients with measurable disease refractory to Anti-PD-1 or Anti-PD-L1 agents.

SWOG S1512 – Phase II trial of PD-1 blockade with Pembrolizumab in resectable or unresectable desmoplastic melanoma. Also requires measurable disease

SWOG S1607 – Phase II trial combining T-VEC (talimogene laherparepvec) + Pembroluzumab in patients with in Stage IV or unresectable Stage III melanoma patients with measurable disease who have progressed on Anti-PD1/L1 based therapy. Patients must have 2 cutaneous, subcutaneous or nodal lesions which are injectable.

Bibliography

Pinheiro AD (2002) Parotid neoplasms: the lump near the mandible? Current Surgery 59:509-517.

Pinheiro AD, Foote RL, McCaffrey TV, Kasperbauer JL, Bonner JA, Olsen KD, Cha S, Sargent D

  • Intraoperative radiotherapy for head and neck and skull base cancer. Head and Neck,

25:217-226.

Boahene DK, Olsen KD, Lewis JE, Pinheiro AD, Pankratz VS, Bagniewski SM (2004)

Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience.

Arch Otolaryngol Head Neck Surg. 130(7):849-56.

Kay PA, Pinheiro AD, Lohse CM, Pankratz VS, Olsen KD, Lewis JE, Nascimento AG. (2004)

Desmoplastic melanoma of the head and neck: histopathologic and immunohistochemical

study of 28 cases. Int J Surg Pathol. 2004 12(1):17-24

Shashy RG, Pinheiro AD, Olsen KD (2006) Toxoplasmosis lymphadenitis presenting as a parotid

mass: a report of 2 cases. Ear Nose Throat J. 2006 Oct;85(10):666-8

Pinheiro AD (2015) Oropharynx cancer: a sexually transmitted disease? Journal of the Greene

            County Medical Society, 73(1):8-9.

Pinheiro AD, Kramar RW (2016) Determinants of Cost in the Treatment of T1-T3 Oropharynx

Cancer. International journal of radiation oncology, biology, physics 94(4):866

DOI10.1016/j.ijrobp.2015.12.026

Published on by Michael Hinni

michael Hinni – Phoenix, Arizona

Practice Contact Information

Mayo Clinic
5777 East Mayo Boulevard

Phoenix
Arizona
85054
United States

Phone: 480-342-2928
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon

Biography/Statement

Michael Hinni MD is Professor at Mayo Clinic College of Medicine; and Chair, Department of Otolaryngology – Head and Neck Surgery at Mayo Clinic.  He received his MD degree at the University of Missouri–Kansas City and completed residency at Mayo Clinic in Rochester Minnesota.  He then completed a fellowship in Head, Neck and Base of Skull Surgery at the Johannes Gutenberg University Hospital in Mainz Germany.  His clinical and research activities focus mainly on endoscopic transoral surgery for cancer and endocrine surgery.

 

Dr. Hinni has been an active member of multiple societies: American Academy of Otolaryngology Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, Fellow of the American Laryngologic Association, Fellow of the Triological Society and Cancer Committee Chair of the American Bronchoesophagological Association.  He has been director of more than 20 head and neck surgical educational courses and invented surgical tools and laryngoscopes.

 

Dr. Hinni has authored or co-authored over 100 papers in peer-reviewed journals as well as 16 book chapters, as well as edited two textbooks.  He delivered over 200 national and international lectures and numerous additional proffered papers.  He serves on the editorial staff of multiple journals.

 

Clinical Trials

Detection of circulating biomarkers (circulating tumor cells and circulating tumor DNA) in patients with head and neck carcinoma following surgical intervention

Gene expression analysis of oral tongue cancer in young non-smokers

Evaluation of Aggressive Dose De-escalation for Adjuvant Chemoradiation in HPV Associated Oropharynx Squamous Cell Carcinoma

 

Bibliography

Published on by Steven Chang

Steven Chang – Detroit, Michigan

Practice Contact Information

Henry Ford Health System
2799 West Grand Blvd
K-8
Detroit
Michigan
48202
United States

Phone: (313) 916-5741
Email:
Web Site: https://www.henryford.com/physician-directory/c/chang-steven

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon

Biography/Statement

Steven Chang is the Director of the Henry Ford Cancer Institute Head and Neck Cancer program, Leader of the Henry Ford Health System Cancer Epidemiology Prevention and Control Program, Chair of the Henry Ford Cancer Institute Quality and Finance Committee.  He received his undergraduate degree from Johns Hopkins University in Biology.  He completed his medical school training at Johns Hopkins University School of Medicine.  His otolaryngology-head and neck surgery training was at Johns Hopkins Hospital.  Steven then went on to complete an advanced head and neck surgical oncology fellowship at MD Anderson Cancer Center in Houston Texas.  He is currently at Henry Ford Health System as a surgeon scientist with joint appointments in Otolaryngology Head and Neck Surgery Department and Public Health Sciences Department. 

Clinical Trials

Bibliography